Viewing Study NCT06168734

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 2:39 AM
Ignite Modification Date: 2026-02-08 @ 3:50 PM
Study NCT ID: NCT06168734
Status: WITHDRAWN
Last Update Posted: 2025-06-08
First Post: 2023-12-04
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Cefepime-taniborbactam vs Meropenem in Adults With VABP or Ventilated HABP
Sponsor: Venatorx Pharmaceuticals, Inc.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Ventilator-associated Pneumonia View
None Hospital-acquired Pneumonia View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Ventilated Pneumonia View
None Hospital Acquired Pneumonia View
None Bacterial Pneumonia View
None VABP View
None vHABP View